Adoptive Transfer of NY-ESO-1 TCR Engineered Peripheral Blood Mononuclear Cells (PBMC) and Peripheral Blood Stem Cells (PBSC) After a Myeloablative Conditioning Regimen, With Administration of Interleukin-2, in Patients With Advanced Malignancies

Investigator(s):
Theodore Scott Nowicki, M.D., Ph.D.;
Organization: 
UCLA
NCT Number: 
Disease Name: 
Sarcoma/Solid Tumors
Disease Category: 
Trial Phases: 
Phase 1
Trial Status: 
Recruiting
Dr. Theodore Scott Nowicki. Photo courtesy of: UCLA Jonsson Comprehensive Cancer Center
Trial Contact: 

Ignacio Baselga Carretero, Ph.D.
(310) 206-2090
IBaselga@mednet.ucla.edu

Theodore Scott Nowicki, M.D., Ph.D.
(310) 206-2090 
TNowicki@mednet.ucla.edu